Canada has planned to ship 800 vials of its Ebola vaccine to the World Health Organization (WHO) in Geneva to curb the outbreak of the disease.
The experimental vaccines will be distributed by WHO in the countries most affected by the disease, the Public Health Agency of Canada announced.
“The vaccine is undergoing clinical trials on humans at Walter Reed Army Institute of Research in the United States after showing promising results in animal testing,” the agency explained.
As the vaccine is experimental, researchers are not able to predict how many people could be immunized or treated.
The vaccine was developed at Canada’s National Microbiology Laboratory in Winnipeg, Manitoba.
More than 4,500 people, most of them in the West African countries, had lost their lives to Ebola which was first confirmed in March.
Nearly half of the deaths have reportedly occurred in Liberia. The UN health agency said that data gathering problems in the African country had made it difficult for officials to draw exact numbers or conclusions on Ebola.
Ebola is a form of hemorrhagic fever whose symptoms are diarrhea, vomiting and bleeding. The virus spreads through direct contact with infected blood, feces or sweat.
It can also be spread through sexual contact or the unprotected handling of contaminated corpses. There is currently no known cure for Ebola.
RELATED ARTICLES
- Canada to PREEMPTIVELY Arrest People Who MAY Commit Hate Crimes in the Future
- Canada Borderline Bans Christianity, Outlaws Reading Aloud From Bible in Public
- Soviet Canada will Jail people FOR LIFE over Hate Speech and $70K Fines over Conspiracy Theories
- New Canadian Bill Aims to Fine and Jail 'Promotion of Fossil Fuels'
- Australians Facing Unprecedented Rise in Mortality Rates, But Leaders Stay Silent
Loading ...
